NEW YORK (GenomeWeb News) – Genetic testing startup Recombine said yesterday that it has raised $3.3 million in a Series A financing.

New York venture capital firm FirstMark Capital led the round, and other participants included Vast Ventures, Vivek Garipalli, Alexander Saint-Amand, as well as Flatiron Health Co-founders Zach Weinberg and Nat Turner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.